Results 61 to 70 of about 3,721,403 (317)

An extension of a multidimensional Hilbert-type inequality

open access: yesJournal of Inequalities and Applications, 2017
In this paper, by the use of weight coefficients, the transfer formula and the technique of real analysis, a new multidimensional Hilbert-type inequality with multi-parameters and a best possible constant factor is given, which is an extension of some ...
Jianhua Zhong, Bicheng Yang
doaj   +1 more source

On a New Extended Hardy–Hilbert’s Inequality with Parameters

open access: yesMathematics, 2020
In this paper, by introducing parameters and weight functions, with the help of the Euler−Maclaurin summation formula, we establish the extension of Hardy−Hilbert’s inequality and its equivalent forms.
Bicheng Yang, Shanhe Wu, Jianquan Liao
doaj   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Coefficients of half-integral weight modular forms

open access: yesJournal of Number Theory, 2003
Inspired by Kolyvagin's celebrated work on the Birch and Swinnerton-Dyer Conjecture and works of Waldspurger, Kohnen and Zagier relating the Fourier coefficients of half-integral weight Hecke eigenforms to values of modular \(L\)-functions (there have been a number of works on the indivisibility of the coefficients of half-integral weight modular forms)
Bruinier, Jan H., Ono, Ken
openaire   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Matrix Weighting of Several Regression Coefficient Vectors

open access: yesThe Annals of Statistics, 1993
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
James, Alan T., Venables, William N.
openaire   +2 more sources

Walangkura Napanangka, Kintore, Northern Territory, 2007 [picture] /

open access: yes, 2007
Title devised by cataloguer based on inscriptions.; Part of the collection: Portraits of prominent indigenous artists of the Western Desert region of the Northern Territory, 2007.; Inscriptions: "A/P GW"--In ink below image; Photographer's blind stamp ...
Weight, Greg, 1946-
core  

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

Long Jack Phillipus Tjakamarra, Northern Territory, 2007 [picture] /

open access: yes, 2007
Title devised by cataloguer based on inscriptions.; Part of the collection: Portraits of prominent indigenous artists of the Western Desert region of the Northern Territory, 2007.; Inscriptions: Photographer's blind stamp lower right corner; "A/P Long ...
Weight, Greg, 1946-
core  

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy